Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diprivan and liver]

F Servin1

  • 1Département d'Anesthésie-Réanimation, Hôpital Bichat, Paris.

Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Propofol is safe for anesthesia in patients with moderate liver cirrhosis, with no observed hepatotoxicity. Dosage adjustments are crucial for severe hepatic failure and alcoholic patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the clinical or pharmaco-economical benefit of target controlled desflurane delivery in surgical patients using the Zeus anaesthesia machine.

Anaesthesia·2009
Same author

Evaluation of the predictive performance of four pharmacokinetic models for propofol.

British journal of anaesthesia·2009
Same author

Light or deep general anaesthesia: does it matter and how to assess it?

European journal of anaesthesiology·2008
Same author

Propofol sedation using Diprifusor target-controlled infusion in adult intensive care unit patients.

Anaesthesia·2004
Same author

Desflurane-remifentanil-nitrous oxide anaesthesia for abdominal surgery: optimal concentrations and recovery features.

Acta anaesthesiologica Scandinavica·2004
Same author

[Target controlled infusion (TCI) anesthesia using propofol. Assessment of training and practice in the operating room].

Annales francaises d'anesthesie et de reanimation·2001
Same journal

Annales francaises d'anesthesie et de reanimation·2020
Same journal

[Multimodal approach to enhance filter lifespan: are all actions equal?].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Disparity of French Emergency medical services equipment: disparity of funding allocation or of management quality?].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Eligibility to a Maastricht III - type organ donation according to the protocol proposed by the French organ procurement organization (Agence de la biomedicine) among patients in a medico surgical intensive care unit].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Enhanced recovery after elective colorectal surgery: reply].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Aorto-right atrial fistula as complication of aortic dissection].

Annales francaises d'anesthesie et de reanimation·2014
See all related articles

Area of Science:

  • Anesthesiology
  • Hepatology
  • Pharmacology

Context:

  • Propofol is a widely used anesthetic agent.
  • Liver function can be significantly impacted by cirrhosis and hepatic failure.
  • Understanding drug metabolism and safety in patients with liver disease is critical.

Purpose:

  • To evaluate the safety and efficacy of propofol in patients with liver cirrhosis.
  • To determine appropriate propofol dosing strategies for patients with varying degrees of hepatic impairment.

Summary:

  • Propofol demonstrated no evidence of hepatotoxicity in patients with moderate liver cirrhosis.
  • Liver blood flow is preserved during propofol administration in these patients.
  • Dosage individualization is essential, with increased requirements noted in chronic alcoholic patients without cirrhosis.

Related Experiment Videos

Impact:

  • Propofol can be safely utilized for anesthesia in patients with moderate liver cirrhosis.
  • Further research is needed to establish safety and efficacy in severe hepatic failure and cholestasis.
  • This information aids clinicians in optimizing anesthetic management for liver disease patients.